| 000 | 01396 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517092704.0 | ||
| 264 | 0 | _c20160516 | |
| 008 | 201605s 0 0 eng d | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWhite, Robert S | |
| 245 | 0 | 0 |
_aPharmaceutical and Medical Devices: FDA Oversight. _h[electronic resource] |
| 260 |
_bIssue brief (Health Policy Tracking Service) _cDec 2015 |
||
| 300 |
_a1-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aConsumer Product Safety |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 |
_aDrug Approval _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug Compounding _xstandards |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 |
_aDrugs, Generic _xstandards |
| 650 | 0 | 4 | _aElectronic Health Records |
| 650 | 0 | 4 |
_aElectronic Nicotine Delivery Systems _xadverse effects |
| 650 | 0 | 4 | _aGovernment Regulation |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 |
_aHepatitis C _xdrug therapy |
| 650 | 0 | 4 | _aHomeopathy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLegislation, Drug |
| 650 | 0 | 4 | _aOrphan Drug Production |
| 650 | 0 | 4 | _aProduct Labeling |
| 650 | 0 | 4 | _aQuality Control |
| 650 | 0 | 4 | _aState Government |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 |
_aUnited States Food and Drug Administration _xlegislation & jurisprudence |
| 773 | 0 |
_tIssue brief (Health Policy Tracking Service) _gp. 1-97 |
|
| 999 |
_c25961065 _d25961065 |
||